The DOI matches its Crossref record; 268 of the 268 references it cites were found in a registry or an index.
Cellular and molecular neuropathology of the cuprizone mouse model: Clinical relevance for multiple sclerosis
Open accessAbstract
The cuprizone mouse model allows the investigation of the complex molecular mechanisms behind nonautoimmune-mediated demyelination and spontaneous remyelination. While it is generally accepted that oligodendrocytes are specifically vulnerable to cuprizone intoxication due to their high metabolic demands, a comprehensive overview of the etiology of cuprizone-induced pathology is still missing to date. In this review we extensively describe the physico-chemical mode of action of cuprizone and discuss the molecular and enzymatic mechanisms by which cuprizone induces metabolic stress, oligodendrocyte apoptosis, myelin degeneration and eventually axonal and neuronal pathology. In addition, we describe the dual effector function of the immune system which tightly controls demyelination by effective induction of oligodendrocyte apoptosis, but in contrast also paves the way for fast and efficient remyelination by the secretion of neurotrophic factors and the clearance of cellular and myelinic debris. Finally, we discuss the many clinical symptoms that can be observed following cuprizone treatment, and how these strengthened the cuprizone model as a useful tool to study human multiple sclerosis, schizophrenia and epilepsy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly this apoptosis precedes the massive demyelination caused by cuprizone administration [18], indicating that oligodendrocyte degeneration is the main cause, as opposed to a secondary immune response.”
From Strain differences in cuprizone induced demyelination (2017) · cites this paper as [18]
In the citing paper
“In addition to the direct effect of cuprizone on oligodendrocytes, the involvement of the brain’s resident neuroinflammatory cells such as microglia and astrocyes is also believed to be responsible for the massive demyelination occurring at 4 weeks time point of cuprizone exposure [18].”
From Strain differences in cuprizone induced demyelination (2017) · cites this paper as [18]
In the citing paper
“Nevertheless, a consensus seems to be that cuprizone selectively affects oligodendrocytes.”
From Strain differences in cuprizone induced demyelination (2017) · cites this paper as [18]
In the citing paper
“Astrocytes and microglia collaborate through the release of cytokines, chemokines, and other, yet to be identified factors, to drive demyelination [79, 107], preventing the release of specific cytokines or chemokines, restricting astrocyte reactivity, or ablating microglia all reduce cuprizone-induced demyelination [107, 181, 189, 243].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [107]
In the citing paper
“The cuprizone model is based on oral ingestion of the copper chelator cuprizone, causing metabolic oligodendrocyte injury.”
From Insights and challenges on animal models for progressive multiple sclerosis (2026) · cites this paper as [183]
In the citing paper
“These include cuprizone (CUP), a chemical toxin, which when provided in the diet of adult mice results in reliable demyelination of the corpus callosum (CC). Upon removal of CUP from the diet, there is robust remyelination (Matsushima & Morrell, 2001; Praet, et al, 2014; Wergeland, Torkildsen, Myhr, Mørk, & Bø et al, 2012).”
From Activated microglia drive demyelination via CSF1R signaling (2021) · cites this paper as Praet, et al, 2014
In the citing paper
“In the following chapter we will briefly introduce the cuprizone model, a toxin-induced demyelination model [21,22].”
From The Cuprizone Model: Dos and Do Nots (2020) · cites this paper as [22]
In the citing paper
“Oral intoxication with the copper-chelator cuprizone induces oligodendrocyte apoptosis within a few days, which is closely followed by the activation of the innate immune cells in the brain, i.e., astrocytes and microglia, finally leading to demyelination of distinct white and grey matter brain areas.”
From The Cuprizone Model: Dos and Do Nots (2020) · cites this paper as [22]
In the citing paper
“Mitochondrial injury and oxidative stress are believed to be fundamental elements of CPZ induced pathology (66).”
From Absence of miRNA-146a Differentially Alters Microglia Function and Proteome (2020) · cites this paper as [66]
Citations
Cites
Endoplasmic reticulum stress: cell life and death decisions
Xu, C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26373 · Cited by 2,291
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
Baumann, N., & Pham-Dinh, D. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.871 · Cited by 1,828
Demyelination increases radial diffusivity in corpus callosum of mouse brain
Song, S.-K., Yoshino, J., Le, T. Q., Lin, S.-J., Sun, S.-W., Cross, A. H., & Armstrong, R. C. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.01.028 · Cited by 1,658
Endoplasmic Reticulum Stress and Oxidative Stress: A Vicious Cycle or a Double-Edged Sword?
Malhotra, J. D., & Kaufman, R. J. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1782 · Cited by 1,588
The yin and yang of neurotrophin action
Lu, B., Pang, P. T., & Woo, N. H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1726 · Cited by 1,356
Bak, L. K., Schousboe, A., & Waagepetersen, H. S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03913.x · Cited by 1,114
Debris clearance by microglia: an essential link between degeneration and regeneration
Neumann, H., Kotter, M. R., & Franklin, R. J. M. (2008) · Brain · doi:10.1093/brain/awn109 · Cited by 1,111
TNFα promotes proliferation of oligodendrocyte progenitors and remyelination
Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y. (2001) · Nature Neuroscience · doi:10.1038/nn738 · Cited by 1,012
Matsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984
Myelin Impairs CNS Remyelination by Inhibiting Oligodendrocyte Precursor Cell Differentiation
Kotter, M. R., Li, W.-W., Zhao, C., & Franklin, R. J. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2615-05.2006 · Cited by 768
Cited by
Sorted by citations
TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge
Nugent, A. A., Lin, K., van Lengerich, B., Lianoglou, S., Przybyla, L., Davis, S. S., Llapashtica, C., Wang, J., Kim, D. J., Xia, D., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.007 · Cited by 745
Multiple sclerosis: experimental models and reality
Lassmann, H., & Bradl, M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1631-4 · Cited by 525
Glial Cells and Their Function in the Adult Brain: A Journey through the History of Their Ablation
Jäkel, S., & Dimou, L. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00024 · Cited by 571
Mitochondrial Dysfunction and Multiple Sclerosis
de Barcelos, I. P., Troxell, R. M., & Graves, J. (2019) · Biology · doi:10.3390/biology8020037 · Cited by 293
Neurosteroids as regulators of neuroinflammation
Yılmaz, C., Karali, K., Fodelianaki, G., Gravanis, A., Chavakis, T., Charalampopoulos, I., & Alexaki, V. I. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100788 · Cited by 261
Zirngibl, M., Assinck, P., Sizov, A., Caprariello, A. V., & Plemel, J. R. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00538-8 · Cited by 233
Multiple sclerosis animal models: a clinical and histopathological perspective
Kipp, M., Nyamoya, S., Hochstrasser, T., & Amor, S. (2017) · Brain Pathology · doi:10.1111/bpa.12454 · Cited by 226
Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function
Spiteri, A. G., Wishart, C. L., Pamphlett, R., Locatelli, G., & King, N. J. C. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02384-2 · Cited by 216
Copper signalling: causes and consequences
Kardos, J., Héja, L., Simon, Á., Jablonkai, I., Kovács, R., & Jemnitz, K. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0277-3 · Cited by 223
Jelescu, I. O., Zurek, M., Winters, K. V., Veraart, J., Rajaratnam, A., Kim, N. S., Babb, J. S., Shepherd, T. M., Novikov, D. S., Kim, S. G., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.02.004 · Cited by 188
Five Decades of Cuprizone, an Updated Model to Replicate Demyelinating Diseases
Vega-Riquer, J. M., Mendez-Victoriano, G., Morales-Luckie, R. A., & Gonzalez-Perez, O. (2019) · Current Neuropharmacology · doi:10.2174/1570159x15666170717120343 · Cited by 188
Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis
Bjelobaba, I. M., Begović-Kuprešanin, V., Peković, S., & Lavrnja, I. C. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24224 · Cited by 197
TSPO in diverse CNS pathologies and psychiatric disease: a critical review and a way forward
Guilarte, T. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.003 · Cited by 173
The Cuprizone Model: Dos and Do Nots
Zhan, J., Mann, T., Joost, S., Behrangi, N., Frank, M., & Kipp, M. (2020) · Cells · doi:10.3390/cells9040843 · Cited by 171
Neuroprotective Potential of Ellagic Acid: A Critical Review
Gupta, A., Singh, A. K., Kumar, R., Jamieson, S., Pandey, A. K., & Bishayee, A. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab007 · Cited by 176
Guglielmetti, C., Veraart, J., Roelant, E., Mai, Z., Daans, J., Audekerke, J. V., Naeyaert, M., Vanhoutte, G., y Palacios, R. D., Praet, J., et al. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.10.052 · Cited by 160
Self-citationSen, M. K., Mahns, D. A., Coorssen, J. R., & Shortland, P. J. (2022) · Glia · doi:10.1002/glia.24148 · Cited by 172
Tanaka, M., Szabó, Á., Spekker, E., Polyák, H., Tóth, F., & Vécsei, L. (2022) · Cells · doi:10.3390/cells11162607 · Cited by 164
Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humans
Fleischer, V., Gonzalez-Escamilla, G., Ciolac, D., Albrecht, P., Küry, P., Gruchot, J., Dietrich, M., Hecker, C., Müntefering, T., Bock, S., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025000118 · Cited by 152
Graph theoretical framework of brain networks in multiple sclerosis: a review of concepts
Fleischer, V., Radetz, A., Ciolac, D., Muthuraman, M., Gonzalez-Escamilla, G., Zipp, F., & Groppa, S. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2017.10.033 · Cited by 151
Activated microglia drive demyelination via CSF1R signaling
Marzan, D. E., Brügger‐Verdon, V., West, B. L., Liddelow, S., Samanta, J., & Salzer, J. L. (2021) · Glia · doi:10.1002/glia.23980 · Cited by 147
Ghaiad, H. R., Nooh, M. M., El‐Sawalhi, M. M., & Shaheen, A. A. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9891-5 · Cited by 141
Microglial Phenotypes and Functions in Multiple SclerosisPreprint
O'Loughlin, E. K., Madore, C., Lassmann, H., & Butovsky, O. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028993 · Cited by 133
Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation
Steelman, A. J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00520 · Cited by 131
Zhang, Y., Li, X., Ćirić, B., Curtis, M. T., Chen, W., Rostami, A. M., & Zhang, G. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000208117 · Cited by 105
Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model
Berghoff, S. A., Düking, T., Spieth, L., Winchenbach, J., Stumpf, S. K., Gerndt, N., Kusch, K., Ruhwedel, T., Möbius, W., & Saher, G. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0497-6 · Cited by 100
Behavioural phenotypes in the cuprizone model of central nervous system demyelination
Sen, M. K., Mahns, D. A., Coorssen, J. R., & Shortland, P. J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.08.008 · Cited by 101
NLR-Dependent Regulation of Inflammation in Multiple Sclerosis
Gharagozloo, M., Gris, K. V., Mahvelati, T. M., Amrani, A., Lukens, J. R., & Gris, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.02012 · Cited by 98
Diversity of Reactive Astrogliosis in CNS Pathology: Heterogeneity or Plasticity?
Moulson, A. J., Squair, J. W., Franklin, R. J. M., Tetzlaff, W., & Assinck, P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.703810 · Cited by 97
Jiang, T., Zhang, L., Pan, X., Zheng, H., Chen, X., Li, L., Luo, J., & Hu, X. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00404 · Cited by 91
Robinson, A. P., Zhang, J. Z., Titus, H. E., Karl, M., Merzliakov, M., Dorfman, A. R., Karlik, S., Stewart, M. G., Watt, R. K., Facer, B. D., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58709-w · Cited by 87
Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications
Palle, P., Monaghan, K. L., Milne, S. M., & Wan, E. C. K. (2017) · Medical Sciences · doi:10.3390/medsci5040023 · Cited by 91
Papazian, I., Tsoukala, E., Boutou, A., Καραμίτα, Μ., Kambas, K., Iliopoulou, L., Fischer, R., Kontermann, R. E., Denis, M. C., Kollias, G. A., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02200-4 · Cited by 87
Guglielmetti, C., Najac, C., Didonna, A., der Linden, A. V., Ronen, S. M., & Chaumeil, M. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613345114 · Cited by 83
Self-citationMicroglial NLRP3 inflammasome activation in multiple sclerosis
(2020) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.08.007 · Cited by 83
Wang, N., Wang, M., Jeevaratnam, S., Rosenberg, C., Ikezu, T. C., Shue, F., Doss, S. V., Alnobani, A., Martens, Y. A., Wren, M., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00577-1 · Cited by 82
Fluorescent flavonoids for endoplasmic reticulum cell imaging
McDonald, L., Liu, B., Taraboletti, A., Whiddon, K. T., Shriver, L. P., Konopka, M., Liu, Q., & Pang, Y. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb02456d · Cited by 82
Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus–Merzbacher disease
Stumpf, S. K., Berghoff, S. A., Trevisiol, A., Spieth, L., Düking, T., Schneider, L. V., Schlaphoff, L., Dreha‐Kulaczewski, S. F., Bley, A. E., Burfeind, D., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01985-2 · Cited by 83
An overall view of the most common experimental models for multiple sclerosis
Dedoni, S., Scherma, M., Camoglio, C., Siddi, C., Dazzi, L., Puliga, R., Frau, J., Cocco, E., & Fadda, P. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106230 · Cited by 79
Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis
Patergnani, S., Bonora, M., Ingusci, S., Previati, M., Marchi, S., Zucchini, S., Perrone, M., Wieckowski, M. R., Castellazzi, M., Pugliatti, M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020078118 · Cited by 78
Guglielmetti, C., Le Blon, D., Santermans, E., Salas-Perdomo, A., Daans, J., De Vocht, N., Shah, D., Hoornaert, C., Praet, J., Peerlings, J., et al. (2016) · Glia · doi:10.1002/glia.23053 · Cited by 76
Self-citationSanadgol, N., Barati, M., Houshmand, F., Hassani, S., Clarner, T., Shahlaei, M., & Golab, F. (2019) · Pharmacological Reports · doi:10.1007/s43440-019-00019-8 · Cited by 74
Acute and chronic demyelinated CNS lesions exhibit opposite elastic properties
Urbanski, M. M., Brendel, M., & Melendez‐Vasquez, C. V. (2019) · Scientific Reports · doi:10.1038/s41598-018-37745-7 · Cited by 78
Faizi, M., Salimi, A., Seydi, E., Naserzadeh, P., Kouhnavard, M., Rahimi, A., & Pourahmad, J. (2016) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2016.1172284 · Cited by 71
Multiple Sclerosis: Perspectives in Treatment and Pathogenesis
Palumbo, S., & PELLEGRINI, S. (2017) · Codon Publications eBooks · doi:10.15586/codon.multiplesclerosis.2017 · Cited by 71
Psenicka, M. W., Smith, B. C., Tinkey, R. A., & Williams, J. L. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.654284 · Cited by 73
Microglial Hv1 proton channel promotes cuprizone‐induced demyelination through oxidative damage
Liu, J., Tian, D., Murugan, M., Eyo, U. B., Dreyfus, C. F., Wang, W., & Wu, L. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13242 · Cited by 72
Chronic demyelination-induced seizures
Lapato, A. S., Szu, J. I., Hasselmann, J., Khalaj, A. J., Binder, D. K., & Tiwari-Woodruff, S. K. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.01.035 · Cited by 66
Viral infections and multiple sclerosis
Donati, D. (2020) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2020.02.003 · Cited by 72
Cuprizone-Induced Demyelination in Mouse Hippocampus Is Alleviated by Ketogenic Diet
Liu, C., Zhang, N., Zhang, R., Jin, L., Petridis, A. K., Loers, G., Zheng, X., Wang, Z., & Siebert, H. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c04604 · Cited by 65
Mandolesi, G., Bullitta, S., Fresegna, D., Vito, F. D., Rizzo, F. R., Musella, A., Guadalupi, L., Vanni, V., Bassi, M. S., Buttari, F., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.05.010 · Cited by 65
Complement-associated loss of CA2 inhibitory synapses in the demyelinated hippocampus impairs memory
Ramaglia, V., Dubey, M., Malpede, A. M., Petersen, N., de Vries, S. I., Ahmed, S. M., Lee, D. S. W., Schenk, G. J., Gold, S. M., Huitinga, I., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02338-8 · Cited by 63
Therapeutic potential of triptolide in autoimmune diseases and strategies to reduce its toxicity
Cheng, Y., Zhao, Y., & Zheng, Y. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00525-z · Cited by 62
A hypothesis for the role of axon demyelination in seizure generation
de Curtis, M., Garbelli, R., & Uva, L. (2021) · Epilepsia · doi:10.1111/epi.16824 · Cited by 57
Sághy, É., Sipos, É., Ács, P., Bölcskei, K., Pohóczky, K., Kemény, Á., Zoltán, S., Szőke, É., Sétáló, G., Komoly, S., et al. (2016) · Glia · doi:10.1002/glia.23051 · Cited by 63
Retinal Cell Degeneration in Animal Models
Niwa, M., Aoki, H., Hirata, A., Tomita, H., Green, P. G., & Hara, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010110 · Cited by 59
Zamora, N. N., Cheli, V. T., González, D. A. S., Wan, R., & Paez, P. M. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1644-19.2020 · Cited by 58
Abdi, M., Pasbakhsh, P., Shabani, M., Nekoonam, S., Sadeghi, A., Fathi, F., Abouzaripour, M., Mohamed, W. M. Y., Zibara, K., Kashani, I. R., et al. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00417-y · Cited by 57
MiR-146a promotes remyelination in a cuprizone model of demyelinating injury
Zhang, J., Zhang, Z. G., Lu, M., Wang, X., Shang, X., Elias, S. B., & Chopp, M. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.02.029 · Cited by 56
Sanadgol, N., Golab, F., Tashakkor, Z., Taki, N., Kouchi, S. M., Mostafaie, A., Mehdizadeh, M., Abdollahi, M. R., Taghizadeh, G., & Sharifzadeh, M. S. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1319867 · Cited by 58
RetractedRevisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse?
Sen, M. K., Almuslehi, M. S. M., Shortland, P. J., Coorssen, J. R., & Mahns, D. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.572186 · Cited by 59
Polyák, H., Galla, Z., Nánási, N., Cseh, E. K., Rajda, C., Veres, G., Spekker, E., Szabó, Á., Klivènyi, P., Tanaka, M., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11030945 · Cited by 56
Tahmasebi, F., Pasbakhsh, P., Mortezaee, K., Madadi, S., Barati, S., & Kashani, I. R. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28344 · Cited by 56
Melchor, G. S., Khan, T., Reger, J., & Huang, J. K. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00068 · Cited by 55
Blon, D. L., Guglielmetti, C., Hoornaert, C., Quarta, A., Daans, J., Dooley, D., Lemmens, E., Praet, J., Vocht, N. D., Reekmans, K., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0756-7 · Cited by 56
Self-citationAboTaleb, H. A., & Alghamdi, B. S. A. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01425-6 · Cited by 54
Wu, X., Liao, B.-Y., Xiao, D., Wu, W., Xiao, Y., Alexander, T. D., Song, S., Zhao, Z.-H., Zhang, Y., Wang, Z., et al. (2021) · Biomaterials Science · doi:10.1039/d1bm01142a · Cited by 51
Harnessing human iPSC-microglia for CNS-wide delivery of disease-modifying proteins
Chadarevian, J. P., Davtyan, H., Chadarevian, A. L., Nguyen, J., Capocchi, J. K., Le, L., Escobar, A., Chadarevian, T., Mansour, K., Deynega, E., et al. (2025) · Cell Stem Cell · doi:10.1016/j.stem.2025.03.009 · Cited by 60
Deletion of CD38 Suppresses Glial Activation and Neuroinflammation in a Mouse Model of Demyelination
Roboon, J., Hattori, T., Ishii, H., Takarada‐Iemata, M., Le, T. M., Shiraishi, Y., Ozaki, N., Yamamoto, Y., Sugawara, A., Okamoto, H., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00258 · Cited by 52
Cuprizone feed formulation influences the extent of demyelinating disease pathology
Toomey, L. M., Papini, M. G., Lins, B. R., Wright, A. J., Warnock, A., McGonigle, T. A., Hellewell, S. C., Bartlett, C. A., Anyaegbu, C. C., & Fitzgerald, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-01963-3 · Cited by 50
Xuan, Y., Yan, G., Wu, R., Huang, Q., Li, X., & Xu, H. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.08.015 · Cited by 50
Zimmermann, J., Emrich, M., Krauthausen, M., Saxe, S., Nitsch, L., Heneka, M. T., Campbell, I. L., & Müller, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0368-3 · Cited by 52
Bölcskei, K., Kriszta, G., Sághy, É., Payrits, M., Sipos, É., Vranesics, A., Berente, Z., Ábrahám, H., Ács, P., Komoly, S., et al. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.020 · Cited by 51
Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis
Plastini, M. J., Desu, H. L., & Brambilla, R. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00269 · Cited by 48
Wang, H., Liu, S., Tian, Y., Wu, X., He, Y., Li, C., Namaka, M., Kong, J., Li, H., & Xiao, L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00492 · Cited by 50
rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination
Mullin, A. P., Cui, C., Wang, Y., Wang, J., Troy, E. L., Caggiano, A. O., Parry, T. J., Colburn, R. W., & Pavlopoulos, E. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.05.015 · Cited by 48
Experimental Demyelination and Axonal Loss Are Reduced in MicroRNA-146a Deficient Mice
Martin, N. A., Molnar, V., Szilagyi, G. T., Elkjaer, M. L., Nawrocki, A., Okarmus, J., Wlodarczyk, A., Thygesen, E. K., Palkovits, M., Gallyas, F., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00490 · Cited by 45
Omotoso, G. O., Gbadamosi, I., Afolabi, T. T., Abdulwahab, A., & Akinlolu, A. (2018) · Anatomy & Cell Biology · doi:10.5115/acb.2018.51.2.119 · Cited by 47
Experimental models of demyelination and remyelination
Torre-Fuentes, L., Moreno-Jiménez, L., Pytel, V., Matías-Guiu, J. A., Gómez-Pinedo, U., & Matías-Guiu, J. (2020) · Neurología (English Edition) · doi:10.1016/j.nrleng.2019.03.007 · Cited by 47
Wellman, S. M., Guzman, K., Stieger, K. C., Brink, L. E., Sridhar, S., Dubaniewicz, M. T., Li, L., Cambi, F., & Kozai, T. D. Y. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119842 · Cited by 44
Shiri, E., Pasbakhsh, P., Borhani‐Haghighi, M., Alizadeh, Z., Nekoonam, S., Mojaverrostami, S., Mahabadi, V. P., Mehdi, A., Zibara, K., & Kashani, I. R. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00910-6 · Cited by 48
Zhao, Z., Li, T., Dong, X., Wang, X., Zhang, Z., Zhao, C., Kang, X., Zheng, R., & Li, X. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/7093844 · Cited by 47
Khodaei, F., Rashedinia, M., Heidari, R., Rezaei, M., & Khoshnoud, M. J. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116954 · Cited by 45
Zhu, K., Sun, J., Zheng, K., Zou, Z., Wu, G.-C., & Wang, J. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00613 · Cited by 46
Modelos experimentales de desmielinización-remielinización
Torre‐Fuentes, L., Moreno‐Jiménez, L., Pytel, V., Matías‐Guiu, J. A., Gómez‐Pinedo, U., & Matías‐Guiu, J. (2017) · Neurología · doi:10.1016/j.nrl.2017.07.002 · Cited by 45
Toxin-Based Models to Investigate Demyelination and Remyelination
McMurran, C. E., Zhao, C., & Franklin, R. J. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9072-6_21 · Cited by 47
Houshmand, F., Barati, M., Golab, F., Ramezani-sefidar, S., Tanbakooie, S., Tabatabaei, M., Amiri, M., & Sanadgol, N. (2019) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-019-00286-z · Cited by 44
Inflammatory demyelination alters subcortical visual circuits
Araújo, S. E. S., Mendonça, H. R., Wheeler, N. A., Campello-Costa, P., Jacobs, K. M., Gomes, F. C. A., Fox, M. A., & Fuss, B. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0936-0 · Cited by 43
Life and death of microglia: Mechanisms governing microglial states and fates
Matsudaira, T., & Prinz, M. (2022) · Immunology Letters · doi:10.1016/j.imlet.2022.04.001 · Cited by 47
Sanadgol, N., Golab, F., Mostafaie, A., Mehdizadeh, M., Khalseh, R., Mahmoudi, M., Abdollahi, M. R., Vakilzadeh, G., Taghizadeh, G., & Sharifzadeh, M. S. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.01.023 · Cited by 42
Omotoso, G. O., Inelo, U. I., Arietarhire, L. O., Sulaimon, F. A., & Gbadamosi, I. (2018) · Pathophysiology · doi:10.1016/j.pathophys.2018.04.004 · Cited by 44
de Jong, C. G. H. M., Gabius, H., & Baron, W. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03327-7 · Cited by 44
Zha, Z., Liu, S., Liu, Y., Li, C., & Wang, L. (2022) · Antioxidants · doi:10.3390/antiox11081495 · Cited by 44
Age Influences Microglial Activation After Cuprizone-Induced Demyelination
Klein, B., Mrowetz, H., Barker, C. M., Lange, S., Rivera, F. J., & Aigner, L. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00278 · Cited by 44
Baicalin Promotes CNS Remyelination via PPARγ Signal Pathway
Ai, R.-S., Xing, K., Deng, X., Han, J.-J., Hao, D.-X., Qi, W.-H., Han, B., Yang, Y.-N., Li, X., & Zhang, Y. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001142 · Cited by 41
Strain differences in cuprizone induced demyelination
Yu, Q., Hui, R., Park, J., Huang, Y., Kusnecov, A. W., Dreyfus, C. F., & Zhou, R. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0181-3 · Cited by 40
Jeffries, M. A., McLane, L. E., Khandker, L., Mather, M. L., Evangelou, A. V., Kantak, D., Bourne, J. N., Macklin, W. B., & Wood, T. L. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1377-20.2021 · Cited by 44
McMurran, C. E., Guzman de la Fuente, A., Penalva, R., Ben Menachem-Zidon, O., Dombrowski, Y., Falconer, J., Gonzalez, G. A., Zhao, C., Krause, F. N., Young, A. M. H., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905787116 · Cited by 39
Icariin enhances remyelination process after acute demyelination induced by cuprizone exposure
Zhang, Y., Yin, L., Zheng, N., Zhang, L., Liu, J., Liang, W., & Wang, Q. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.01.025 · Cited by 39
Sun, W., Wen, M., Liu, M., Wang, Q., Liu, Q., Li, L., Siebert, H., Loers, G., Zhang, R., & Zhang, N. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1075161 · Cited by 39
Metadata
- Authors
- Praet, J., Guglielmetti, C., Berneman, Z., Van der Linden, A., & Ponsaerts, P.
- Affiliations
- University of Antwerp (BE)
- Corresponding author
- Praet, Jelle
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 47
- Pages
- 485-505
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W1991883207
- Cited by
- 435
- References
- 268
- Citations by year
- 2026: 29 · 2025: 36 · 2024: 29 · 2023: 37 · 2022: 51 · 2021: 49 · 2020: 48 · 2019: 49 · 2018: 41 · 2017: 35 · 2016: 19 · 2015: 12
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Neuroscience & Biobehavioral Reviews (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Fund for Scientific Research-Flanders
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- cuprizone, multiple sclerosis, demyelination, remyelination, oligodendrocyte apoptosis, myelin degeneration, metabolic stress, neuroinflammation, neurotrophic factors, myelin debris clearance, axonal pathology, neuronal pathology, schizophrenia, epilepsy, mouse model
- MeSH terms
- Animals, Brain, Cuprizone, Disease Models, Animal, Multiple Sclerosis, Myelin Sheath, Neuroglia, Neurons, Oxidative Stress, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
